These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2167697)

  • 21. Acetyl glyceryl ether phosphorylcholine (PAF-acether) and leukotriene B4-mediated neutrophil chemotaxis through an intact endothelial cell monolayer.
    Hopkins NK; Schaub RG; Gorman RR
    Biochim Biophys Acta; 1984 Sep; 805(1):30-6. PubMed ID: 6089913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methotrexate inhibits the leukotriene B4 induced intraepidermal accumulation of polymorphonuclear leukocytes.
    van de Kerkhof PC; Bauer FW; Maassen-de Grood RM
    Br J Dermatol; 1985 Sep; 113(3):251a-255a. PubMed ID: 2998429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological activities of isomers of 8,15-dihydroxyeicosatetraenoic acid.
    Evans J; Ford-Hutchinson AW; Fitzsimmons B; Rokach J
    Prostaglandins; 1984 Sep; 28(3):435-8. PubMed ID: 6096926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of human neutrophils.
    Ternowitz T; Fogh K; Kragballe K
    Skin Pharmacol; 1988; 1(2):93-9. PubMed ID: 2856182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 6-trans-leukotriene B4 is a neutrophil chemotaxin in the guinea pig dermis.
    Fretland DJ; Widomski DL; Anglin CP; Walsh RE; Levin S; Gaginella TS
    J Leukoc Biol; 1991 Mar; 49(3):283-8. PubMed ID: 1847716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphonuclear leucocyte chemotaxis in response to leukotriene B4 in treated and untreated psoriatics.
    Green CM; Ferguson J; MacLeod TM; Millar BW; Raffle EJ
    Dermatologica; 1989; 178(1):20-2. PubMed ID: 2537239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological properties of dihydro-leukotriene B4, an alternative leukotriene B4 metabolite.
    Kaever V; Damerau B; Wessel K; Resch K
    FEBS Lett; 1988 Apr; 231(2):385-8. PubMed ID: 2834233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of low dose methotrexate on neutrophil chemotaxis induced by leukotriene B4 and complement C5a.
    Suarez CR; Pickett WC; Bell DH; McClintock DK; Oronsky AL; Kerwar SS
    J Rheumatol; 1987 Feb; 14(1):9-11. PubMed ID: 3033240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of leukotriene B4 as a mediator of leucocyte function.
    Ford-Hutchinson AW
    Agents Actions Suppl; 1983; 12():154-66. PubMed ID: 6301230
    [No Abstract]   [Full Text] [Related]  

  • 30. Reduction of leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes by methotrexate in psoriasis.
    Lammers AM; van de Kerkhof PC; Mier PD
    Br J Dermatol; 1987 May; 116(5):667-71. PubMed ID: 3036194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukotriene B4 fails to induce penetration of polymorphonuclear leukocytes into psoriatic lesions.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Nov; 117(5):541-4. PubMed ID: 2825753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3(S)-hydroxy-leukotriene B4 is a potent granulocyte chemotaxin in the guinea pig dermis.
    Fretland D; Anglin C; Baron D; Widomski D; Chauhan K; Bhatt R; Falck J
    Inflamm Res; 1995 Aug; 44 Suppl 2():S137-8. PubMed ID: 8548366
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthetic leukotriene B4 is a potent chemotaxin but a weak secretagogue for human PMN.
    Rollins TE; Zanolari B; Springer MS; Guindon Y; Zamboni R; Lau CK; Rokach J
    Prostaglandins; 1983 Feb; 25(2):281-9. PubMed ID: 6304818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro.
    Spada CS; Nieves AL; Krauss AH; Woodward DF
    J Leukoc Biol; 1994 Feb; 55(2):183-91. PubMed ID: 8301215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effect between leukotriene B4 and leukotriene B5 on the induction of interleukin 1-like activity and calcium mobilizing activity in human blood monocytes.
    Tatsuno I; Saito H; Chang KJ; Tamura Y; Yoshida S
    Agents Actions; 1990 Mar; 29(3-4):324-7. PubMed ID: 2160190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of leukotriene B3: comparison of its biological activities with leukotriene B4 and leukotriene B5 in complement receptor enhancement, lysozyme release and chemotaxis of human neutrophils.
    Lee TH; Sethi T; Crea AE; Peters W; Arm JP; Horton CE; Walport MJ; Spur BW
    Clin Sci (Lond); 1988 May; 74(5):467-75. PubMed ID: 2836122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of topical retinoids on the leukotriene-B4-induced migration of polymorphonuclear leukocytes into human skin.
    Wozel G; Chang A; Zultak M; Czarnetzki BM; Happle R; Barth J; van de Kerkhof PC
    Arch Dermatol Res; 1991; 283(3):158-61. PubMed ID: 1651071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotaxis of polymorphonuclear leukocytes towards LTB4 in patients with psoriasis in vitro.
    Sun RZ; Zhou DY; Zheng MR; Yue TL
    Chin Med J (Engl); 1990 Jul; 103(7):595-8. PubMed ID: 2170083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor-specific mechanisms for the responses of human leukocytes to leukotrienes.
    Goetzl EJ; Sherman JW; Ratnoff WD; Harvey JP; Eriksson E; Seaman WE; Baud L; Koo CH
    Ann N Y Acad Sci; 1988; 524():345-55. PubMed ID: 2837968
    [No Abstract]   [Full Text] [Related]  

  • 40. Dapsone hydroxylamine inhibits the LTB4-induced chemotaxis of polymorphonuclear leukocytes into human skin: results of a pilot study.
    Wozel G; Blasum C; Winter C; Gerlach B
    Inflamm Res; 1997 Oct; 46(10):420-2. PubMed ID: 9372316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.